27.12.2012 Views

A Textbook of Clinical Pharmacology and Therapeutics

A Textbook of Clinical Pharmacology and Therapeutics

A Textbook of Clinical Pharmacology and Therapeutics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ETHICS COMMITTEES<br />

Protocols for all clinical trials must be reviewed <strong>and</strong> approved<br />

by a properly constituted independent ethics committee.<br />

Research Ethics Committees are coordinated by NRES<br />

(National Research Ethics Services) working on behalf <strong>of</strong> the<br />

Department <strong>of</strong> Health in the UK.<br />

NRES maintains a UK-wide system <strong>of</strong> ethical review that<br />

protects the safety, dignity <strong>and</strong> well-being <strong>of</strong> research participants<br />

whilst facilitating <strong>and</strong> promoting research within the<br />

NHS.<br />

Interestingly, studies have shown that patients taking part<br />

in clinical trials <strong>of</strong>ten have better health outcomes than those<br />

not involved in a trial.<br />

GLOBALIZATION<br />

In order to facilitate world-wide drug development <strong>and</strong><br />

encourage good st<strong>and</strong>ards <strong>of</strong> practice, a series <strong>of</strong> international<br />

conferences on harmonization <strong>of</strong> requirements for registration<br />

<strong>of</strong> pharmaceuticals for human use have been conducted.<br />

International Conferences on Harmonisation (ICH) are leading<br />

to a globally accepted system <strong>of</strong> drug development,<br />

hopefully without stifling research with excessive bureaucracy<br />

FURTHER READING<br />

GLOBALIZATION 91<br />

<strong>and</strong> without any lowering <strong>of</strong> st<strong>and</strong>ards. The goal is to facilitate<br />

the early introduction <strong>of</strong> valuable new therapies, while at<br />

the same time maximizing patient protection.<br />

Case history<br />

Rather than a clinical case history, consider a chapter in the<br />

history <strong>of</strong> drug regulation which is instructive in illustrating<br />

the value <strong>of</strong> toxicity testing. Triparanol is a drug that<br />

lowers the concentration <strong>of</strong> cholesterol in plasma. It was<br />

marketed in the USA in 1959. In 1962, the Food <strong>and</strong> Drug<br />

Administration (FDA) received a tip-<strong>of</strong>f <strong>and</strong> undertook an<br />

unannounced inspection. This revealed that toxicology<br />

data demonstrating cataract formation in rats <strong>and</strong> dogs<br />

had been falsified. Triparanol was withdrawn, but some <strong>of</strong><br />

the patients who had been taking it for a year or longer<br />

also developed cataracts.<br />

Collier J (ed.). Drug <strong>and</strong> therapeutics bulletin; from trial outcomes to clinical<br />

practice. London: Which? Ltd, 1996.<br />

Griffin JP, O’Grady J (eds). The textbook <strong>of</strong> pharmaceutical medicine, 5th<br />

edn. London: BMJ Books, 2005.<br />

Wilkins MR (ed.). Experimental therapeutics. Section 1: Drug discovery<br />

<strong>and</strong> development. London: Martin Dunitz, 2003.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!